Caffeine (Caf) is a well‐established ergogenic aid among various training models, including strength and/or power. However, there is limited information on the ergogenic effects of Caf ingestion during many strength and power training models. Purpose: This study investigated the acute effects of Caf ingestion in bench press power and velocity when training sessions were planned using cluster (CL) and traditional (TR) strength training programs. Methods: Twelve trained men (22 ± 1.6 y, 80.4 ± 10.7 kg, 175.6 ± 4.6 cm) ingested 6 mg/kg of Caf one hour before exercise. Then they performed 4 sets of 6 reps on the bench press with 80% of 1 RM at six experimental trials (Cluster: 4 sets of 2 reps with 140‐sec rest between sets, TR: 4 sets of 6 reps with 180‐sec rest between sets) in a randomized, double‐blind placebo (PL)‐controlled, crossover design [CL+Caf, CL+PL, CL+control (CON), TR+Caf, TR+PL, and TR+CON]. The peak and mean power, velocity, and time under tension were evaluated at concentric and eccentric phases during the bench press exercise. Results: We observed that Caf ingestion improves peak and mean power and velocity at concentric and eccentric phases of both training models compared to those in the PL and CON conditions (p < 0.05). There was no significant performance difference between the training models (p > 0.05). The Caf ingestion reduced time under tension at both training models (p < 0.05) compared to that in the PL and CON conditions, while no difference was seen between training models (p > 0.05). Conclusion: Acute Caf ingestion positively affects strength and power training performance regardless of the training models.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.